485 related articles for article (PubMed ID: 21457946)
21. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies.
Honea R; Crow TJ; Passingham D; Mackay CE
Am J Psychiatry; 2005 Dec; 162(12):2233-45. PubMed ID: 16330585
[TBL] [Abstract][Full Text] [Related]
22. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study.
Bartzokis G; Nuechterlein KH; Lu PH; Gitlin M; Rogers S; Mintz J
Biol Psychiatry; 2003 Mar; 53(5):412-21. PubMed ID: 12614994
[TBL] [Abstract][Full Text] [Related]
23. White matter abnormalities in first-episode schizophrenia: a combined structural MRI and DTI study.
Chan WY; Yang GL; Chia MY; Lau IY; Sitoh YY; Nowinski WL; Sim K
Schizophr Res; 2010 Jun; 119(1-3):52-60. PubMed ID: 20056394
[TBL] [Abstract][Full Text] [Related]
24. Progressive brain volume loss during adolescence in childhood-onset schizophrenia.
Sporn AL; Greenstein DK; Gogtay N; Jeffries NO; Lenane M; Gochman P; Clasen LS; Blumenthal J; Giedd JN; Rapoport JL
Am J Psychiatry; 2003 Dec; 160(12):2181-9. PubMed ID: 14638588
[TBL] [Abstract][Full Text] [Related]
25. Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study.
Suddath RL; Casanova MF; Goldberg TE; Daniel DG; Kelsoe JR; Weinberger DR
Am J Psychiatry; 1989 Apr; 146(4):464-72. PubMed ID: 2929746
[TBL] [Abstract][Full Text] [Related]
26. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood.
van Haren NE; Hulshoff Pol HE; Schnack HG; Cahn W; Brans R; Carati I; Rais M; Kahn RS
Biol Psychiatry; 2008 Jan; 63(1):106-13. PubMed ID: 17599810
[TBL] [Abstract][Full Text] [Related]
27. Cerebral atrophy and white matter disruption in chronic schizophrenia.
Andreone N; Tansella M; Cerini R; Rambaldelli G; Versace A; Marrella G; Perlini C; Dusi N; Pelizza L; Balestrieri M; Barbui C; Nosè M; Gasparini A; Brambilla P
Eur Arch Psychiatry Clin Neurosci; 2007 Feb; 257(1):3-11. PubMed ID: 16960652
[TBL] [Abstract][Full Text] [Related]
28. White matter abnormalities in subjects at ultra high-risk for schizophrenia and first-episode schizophrenic patients.
Witthaus H; Brüne M; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Heinz A; Klingebiel R; Juckel G
Schizophr Res; 2008 Jul; 102(1-3):141-9. PubMed ID: 18515047
[TBL] [Abstract][Full Text] [Related]
29. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.
Fusar-Poli P; Smieskova R; Kempton MJ; Ho BC; Andreasen NC; Borgwardt S
Neurosci Biobehav Rev; 2013 Sep; 37(8):1680-91. PubMed ID: 23769814
[TBL] [Abstract][Full Text] [Related]
30. Progressive Reduction in Gray Matter in Patients with Schizophrenia Assessed with MR Imaging by Using Causal Network Analysis.
Jiang Y; Luo C; Li X; Duan M; He H; Chen X; Yang H; Gong J; Chang X; Woelfer M; Biswal BB; Yao D
Radiology; 2018 May; 287(2):633-642. PubMed ID: 29357273
[TBL] [Abstract][Full Text] [Related]
31. Brain volumes as predictor of outcome in recent-onset schizophrenia: a multi-center MRI study.
van Haren NE; Cahn W; Hulshoff Pol HE; Schnack HG; Caspers E; Lemstra A; Sitskoorn MM; Wiersma D; van den Bosch RJ; Dingemans PM; Schene AH; Kahn RS
Schizophr Res; 2003 Nov; 64(1):41-52. PubMed ID: 14511800
[TBL] [Abstract][Full Text] [Related]
32. Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse.
O'Neill J; Cardenas VA; Meyerhoff DJ
Alcohol Clin Exp Res; 2001 Nov; 25(11):1673-82. PubMed ID: 11707642
[TBL] [Abstract][Full Text] [Related]
33. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging.
Lim KO; Hedehus M; Moseley M; de Crespigny A; Sullivan EV; Pfefferbaum A
Arch Gen Psychiatry; 1999 Apr; 56(4):367-74. PubMed ID: 10197834
[TBL] [Abstract][Full Text] [Related]
34. Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient.
Rais M; Cahn W; Schnack HG; Hulshoff Pol HE; Kahn RS; van Haren NE
Psychol Med; 2012 Sep; 42(9):1847-56. PubMed ID: 22357376
[TBL] [Abstract][Full Text] [Related]
35. Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia.
Mandelli ML; Vilaplana E; Brown JA; Hubbard HI; Binney RJ; Attygalle S; Santos-Santos MA; Miller ZA; Pakvasa M; Henry ML; Rosen HJ; Henry RG; Rabinovici GD; Miller BL; Seeley WW; Gorno-Tempini ML
Brain; 2016 Oct; 139(Pt 10):2778-2791. PubMed ID: 27497488
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia.
Mitelman SA; Brickman AM; Shihabuddin L; Newmark RE; Hazlett EA; Haznedar MM; Buchsbaum MS
Neuroimage; 2007 Aug; 37(2):449-62. PubMed ID: 17587598
[TBL] [Abstract][Full Text] [Related]
37. Primary and secondary alterations of white matter connectivity in schizophrenia: A study on first-episode and chronic patients using whole-brain tractography-based analysis.
Wu CH; Hwang TJ; Chen YJ; Hsu YC; Lo YC; Liu CM; Hwu HG; Liu CC; Hsieh MH; Chien YL; Chen CM; Isaac Tseng WY
Schizophr Res; 2015 Dec; 169(1-3):54-61. PubMed ID: 26443482
[TBL] [Abstract][Full Text] [Related]
38. Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM.
Mané A; Falcon C; Mateos JJ; Fernandez-Egea E; Horga G; Lomeña F; Bargalló N; Prats-Galino A; Bernardo M; Parellada E
Schizophr Res; 2009 Oct; 114(1-3):136-43. PubMed ID: 19683418
[TBL] [Abstract][Full Text] [Related]
39. Gray matter volume differences and the effects of smoking on gray matter in schizophrenia.
Tregellas JR; Shatti S; Tanabe JL; Martin LF; Gibson L; Wylie K; Rojas DC
Schizophr Res; 2007 Dec; 97(1-3):242-9. PubMed ID: 17890058
[TBL] [Abstract][Full Text] [Related]
40. Source-based morphometry of gray matter volume in patients with schizophrenia who have persistent auditory verbal hallucinations.
Kubera KM; Sambataro F; Vasic N; Wolf ND; Frasch K; Hirjak D; Thomann PA; Wolf RC
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():102-9. PubMed ID: 24321225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
